Trucept Stock Performance
| TREP Stock | USD 0.02 0 22.79% |
Trucept holds a performance score of 5 on a scale of zero to a hundred. The entity has a beta of -0.28, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Trucept are expected to decrease at a much lower rate. During the bear market, Trucept is likely to outperform the market. Use Trucept downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to analyze future returns on Trucept.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Trucept are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile technical and fundamental indicators, Trucept reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Trucept |
Trucept Relative Risk vs. Return Landscape
If you would invest 1.60 in Trucept on November 6, 2025 and sell it today you would earn a total of 0.07 from holding Trucept or generate 4.37% return on investment over 90 days. Trucept is currently generating 1.011% in daily expected returns and assumes 14.0493% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Trucept, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Trucept Target Price Odds to finish over Current Price
The tendency of Trucept Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.02 | 90 days | 0.02 | about 69.22 |
Based on a normal probability distribution, the odds of Trucept to move above the current price in 90 days from now is about 69.22 (This Trucept probability density function shows the probability of Trucept Pink Sheet to fall within a particular range of prices over 90 days) .
Trucept Price Density |
| Price |
Predictive Modules for Trucept
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Trucept. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Trucept's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trucept Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Trucept is not an exception. The market had few large corrections towards the Trucept's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Trucept, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Trucept within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.85 | |
β | Beta against Dow Jones | -0.28 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.06 |
Trucept Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Trucept for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Trucept can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Trucept is way too risky over 90 days horizon | |
| Trucept has some characteristics of a very speculative penny stock | |
| Trucept appears to be risky and price may revert if volatility continues | |
| Trucept currently holds 1.13 M in liabilities. Trucept has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Trucept until it has trouble settling it off, either with new capital or with free cash flow. So, Trucept's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Trucept sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Trucept to invest in growth at high rates of return. When we think about Trucept's use of debt, we should always consider it together with cash and equity. |
Trucept Fundamentals Growth
Trucept Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Trucept, and Trucept fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Trucept Pink Sheet performance.
| Return On Equity | 0.0036 | |||
| Return On Asset | -0.006 | |||
| Profit Margin | 0 % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 221.15 K | |||
| Shares Outstanding | 50.26 M | |||
| Price To Earning | (0.05) X | |||
| Price To Sales | 0.10 X | |||
| Revenue | 20 M | |||
| EBITDA | (7.28 M) | |||
| Cash And Equivalents | 78.09 K | |||
| Total Debt | 1.13 M | |||
| Book Value Per Share | 0.32 X | |||
| Cash Flow From Operations | 2.44 M | |||
| Earnings Per Share | (0.16) X | |||
| Total Asset | 18.96 M | |||
| Retained Earnings | (21.58 M) | |||
| Current Asset | 4.89 M | |||
| Current Liabilities | 33.22 M | |||
About Trucept Performance
Assessing Trucept's fundamental ratios provides investors with valuable insights into Trucept's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Trucept is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Trucept, Inc., through its subsidiaries, provides business services in the United States. The company was formerly known as Smart-Tek Solutions, Inc. and changed its name to Trucept, Inc. in January 2013. Trucept operates under Staffing Employment Services classification in the United States and is traded on OTC Exchange.Things to note about Trucept performance evaluation
Checking the ongoing alerts about Trucept for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Trucept help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Trucept is way too risky over 90 days horizon | |
| Trucept has some characteristics of a very speculative penny stock | |
| Trucept appears to be risky and price may revert if volatility continues | |
| Trucept currently holds 1.13 M in liabilities. Trucept has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Trucept until it has trouble settling it off, either with new capital or with free cash flow. So, Trucept's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Trucept sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Trucept to invest in growth at high rates of return. When we think about Trucept's use of debt, we should always consider it together with cash and equity. |
- Analyzing Trucept's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Trucept's stock is overvalued or undervalued compared to its peers.
- Examining Trucept's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Trucept's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Trucept's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Trucept's pink sheet. These opinions can provide insight into Trucept's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Trucept Pink Sheet Analysis
When running Trucept's price analysis, check to measure Trucept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trucept is operating at the current time. Most of Trucept's value examination focuses on studying past and present price action to predict the probability of Trucept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trucept's price. Additionally, you may evaluate how the addition of Trucept to your portfolios can decrease your overall portfolio volatility.